Hey, FDA, If You're Not Busy with Other Things... | GenomeWeb

Following the passage of GINA by US Congress, the Wall Street Journal reports that "a federal advisory panel called for tougher government oversight of the burgeoning genetic-testing business, warning that tests are being marketed with little evidence about their usefulness." (Now there's a shock.) The committee says all genetic lab tests should have to undergo stringent evaluation by FDA.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.